Mayo Clinic

Latest Headlines

Latest Headlines

Mayo joins Sanovas to develop lung-clearing asthma treatment

Sanovas, a devicemaker specializing in microinvasive surgery for the lungs, joined forces with the Mayo Clinic to market its outpatient treatment for asthma that relaxes the muscles that constrict the airways.

Mayo Clinic: Metabolomics could be key to early Alzheimer's blood Dx test

A technique known as metabolomics may enable an Alzheimer's disease blood test diagnosis before patients start displaying symptoms, Mayo Clinic scientists have concluded.

Mayo Clinic develops drug that stops growth of kidney cancer

An experimental drug designed to block an overactive protein in kidney cancer may provide a more targeted approach to treating the common cancer and could eventually be used as a therapy for other types of the disease.

Cancer Genetics bags $6.9M in over-allotted IPO

After scaling back its IPO price by about 85%, diagnostics outfit Cancer Genetics has some good news to report, pulling in $6.9 million once its under-writers exercised their over-allotment option.

Mayo Clinic's prostate cancer imaging agent hampered by limited access

With great fanfare, the Mayo Clinic won FDA approval late last year for a new diagnostic imaging agent that helps determine when prostate cancer has returned. But as Bloomberg reports, the non-profit medical center has struggled to expand access to the compound.

Sanford-Burnham, Mayo hunt for drugs against high-priority targets

Two top research organizations have mounted a combined effort to discover new drugs for cancer, Alzheimer's disease and other illnesses.

Mayo study spotlights new biomarkers for quick kidney injury alert

Investigators from the Mayo Clinic say a recent study helped uncover two new biomarkers for acute kidney injury which should flag at-risk patients significantly earlier than currently used biomarkers.

Freshly unstealthed SV Bio teams with Mayo Clinic on genomic Dx

California's SV Bio announced its presence to the world last week, and now the forward-thinking diagnostics outfit is partnering with the Mayo Clinic to bring clinical genome interpretation to Mayo's Center for Individualized Medicine.

New target could improve treatment of deadly pancreatic cancer

With the 5-year survival rate for pancreatic cancer at just 6%--the lowest among all major killer cancers--finding a treatment for the disease could literally be lifesaving for patients.

Regenerative med group aims at reconstructing injured soldiers

As head of the Pentagon's $250 million project on regenerative medicine, Dr. Joachim Kohn has pioneered several new technologies: degradable compounds for drug delivery, the use of polymers and tissue scaffolds to create new body parts or rebuild bone and nerves in war-damaged soldiers.